Conference Coverage

Rivaroxaban bonus: Early unmasking of occult GI cancers

Publish date: September 22, 2018

 

REPORTING FROM THE ESC CONGRESS 2018

Pages

Recommended Reading

Aspirin not prescribed appropriately to cut cardiovascular risk in diabetes
Clinician Reviews
Stroke in AF patients often preceded by inadequate anticoagulation
Clinician Reviews
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
Clinician Reviews
Does warfarin cause acute kidney injury?
Clinician Reviews
First reversal agent for apixaban and rivaroxaban gets fast-track approval
Clinician Reviews
Low vitamin D linked with DVT in lupus patients
Clinician Reviews
Canakinumab cut gout attacks in CANTOS
Clinician Reviews
DOACs’ safety affirmed in real-world setting
Clinician Reviews
Blood pressure control prevents cognitive impairment
Clinician Reviews
New stroke intervention guidelines stress volume
Clinician Reviews